Home > products > custom-nanocomposites
> fluorescent-labeled-nanocomposites
> dotap-dopc-chol-5-65-30-molar-ratio-based-fluoroliposome-dia
DOTAP:DOPC:Chol(5:65:30 molar ratio)-based Fluoroliposome DiA
1,2-dioleoyl-3-trimethylammonium-propane (chloride salt):1,2-dioleoyl-sn-glycero-3-phosphocholine:Cholesterol(5:65:30 molar ratio)-based Fluoroliposome DiA
Product description
DOTAP: DOPC: Chol (5:65:30 molar ratio) - based Fluoroliposome DiA can track the uptake and distribution of liposomes in cell cultures or animal models.Delivery of therapeutic agents, including nucleic acids.
Potential use in mRNA and other types of vaccines, leveraging their ability to deliver genetic material into cells.
| Appearance | N/A |
|---|---|
| Molecular weight | N/A |
| Solubility | N/A |
| Liposome Size | 100 nm |
| 4-(4-(Dihexadecylamino)styryl)-N-methylpyridinium iodide (DiA)-Excitation/Emission (nm) | 456/590 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 3 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of dotap-dopc-chol-5-65-30-molar-ratio-based-fluoroliposome-dia
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


